Study Finds That Long-Term Use of HIV Drugs Doesn't Increase Non-AIDS Death Risk
December 8, 2011
Ever since HAART came about in the mid '90s, the life expectancy among people living with HIV/AIDS has increased significantly. But, there have been some serious questions about the overall safety of taking these medications long-term. These concerns are especially prevalent given the current debates around PrEP, treatment as prevention and whether or not people living with HIV/AIDS should start treatment sooner rather than later.
But a recent study might help quell some of those fears.
Researchers from the EuroSIDA study suggest that prolonged use of antiretroviral therapy does not increase the risk of death from non-AIDS-related illnesses such as heart and kidney disease. According to aidsmap, by analyzing the health outcomes of more than 12,000 people living with HIV/AIDS who started treatment after 1996 and were categorized as being on treatment less than two years, two to three years, four to six years, six to eight years, or more than eight years, the researchers found:
Researchers did however find a correlation between the long-term use of antiretroviral therapy and dying from non-AIDS-related cancers. But they suggested this might be due to the growing aging population of the HIV/AIIDS community or the increase of cancer awareness and screenings over the years.
Kellee Terrell is the former news editor for TheBody.com and TheBodyPRO.com.
Follow Kellee on Twitter: @kelleent.
Copyright © 2011 The HealthCentral Network, Inc. All rights reserved.
This article was provided by TheBody.com.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)
The content on this page is free of advertiser influence and was produced by our editorial team. See our advertising policy.